Alnylam Pharmaceuticals
ALNY
#586
Rank
ยฃ27.88 B
Marketcap
ยฃ216.21
Share price
0.58%
Change (1 day)
49.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company